Literature DB >> 15889191

Homocysteine, lipid profile, nitric oxide, vitamin B12, and folate values in patients with premature coronary artery disease and their children.

Feyzanur Ayse Pac1, Elif Ozerol, Ibrahim Halil Ozerol, Ismail Temel, Erdal Ege, Saim Yologlu, Nurzen Sezgin, Kazim Sahin, Mustafa Emmiler, Mustafa Pac, Halil Aslan.   

Abstract

The plasma concentrations of homocysteine and lipoprotein A are independent risk factors for atherosclerotic vascular disease. Nitric oxide (NO) and folate values are also important in atherogenesis. The authors aimed to evaluate these parameters in patients having coronary artery bypass surgery (CABS) before 50 years of age and in their children. In 31 patients having CABS, 47 children of these patients, and 28 normal control subjects, homocysteine, NO, vitamin B12, folate, lipoprotein A, triglyceride, total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, apolipoprotein A1, and apolipoprotein B values were determined. Homocysteine values of the patients with premature coronary heart diseases and their children were significantly higher than those of controls (p < 0.031 and p < 0.006, respectively). Also, NO levels were significantly higher in both groups than in controls (p < 0.001 and p < 0.031, respectively). B12 values were significantly higher in both groups (p < 0.05 and p < 0.033, respectively). Lipoprotein A levels were higher in both groups but not significantly so.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889191     DOI: 10.1177/000331970505600303

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  1 in total

1.  Metabolic and genetic profiling of young adults with and without a family history of premature coronary heart disease (MAGNETIC). Study design and methodology.

Authors:  Tadeusz Osadnik; Kamila Osadnik; Natalia Pawlas; Joanna Strzelczyk; Janusz Kasperczyk; Lech Poloński; Mariusz Gąsior
Journal:  Arch Med Sci       Date:  2019-02-18       Impact factor: 3.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.